Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis

In patients suffering from multiple sclerosis (MS), intrathecal injection of triamcinolone acetonide (TCA) has been shown to improve symptoms of spasticity. Although repeated intrathecal injection of TCA has been used in a number of studies in late-stage MS patients with spinal cord involvement, no...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Endocrinol (Lausanne)
Autores principales: Hoeflich, Andreas, Fitzner, Brit, Walz, Christina, Hecker, Michael, Tuchscherer, Armin, Bastian, Manuela, Brenmoehl, Julia, Schröder, Ina, Willenberg, Holger S., Reincke, Martin, Zettl, Uwe Klaus
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481359/
https://ncbi.nlm.nih.gov/pubmed/32982971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00574
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares